Boiron SA BOIRF Stock
Boiron SA Price Chart
Boiron SA BOIRF Financial and Trading Overview
Boiron SA stock price | 28.5 USD |
Previous Close | 43.37 USD |
Open | 43.37 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 43.37 - 43.37 USD |
52 Week Range | 39.95 - 49.53 USD |
Volume | 109 USD |
Avg. Volume | 0 USD |
Market Cap | 939.02M USD |
Beta (5Y Monthly) | 0.408812 |
PE Ratio (TTM) | 14.127036 |
EPS (TTM) | 1.42 USD |
Forward Dividend & Yield | 1.02 (2.35%) |
Ex-Dividend Date | June 1, 2023 |
1y Target Est | N/A |
BOIRF Valuation Measures
Enterprise Value | N/A |
Trailing P/E | 14.127036 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.7576685 |
Price/Book (mrq) | 1.4139471 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Boiron SA Stock Price History
Beta (5Y Monthly) | 0.408812 |
52-Week Change | 0.86% |
S&P500 52-Week Change | 20.43% |
52 Week High | 49.53 USD |
52 Week Low | 39.95 USD |
50-Day Moving Average | 43.37 USD |
200-Day Moving Average | 43.5 USD |
BOIRF Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 17.36M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 75.48% |
% Held by Institutions | 9.13% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.1 |
Trailing Annual Dividend Yield | 2.53% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.32869998 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.36% |
Operating Margin (ttm) | 12.80% |
Gross Margin | 71.07% |
EBITDA Margin | 16.78% |
Management Effectiveness
Return on Assets (ttm) | 5.48% |
Return on Equity (ttm) | 8.13% |
Income Statement
Revenue (ttm) | 534.24M USD |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 4.59% |
Gross Profit (ttm) | 379.73M USD |
EBITDA | 89.69M USD |
Net Income Avi to Common (ttm) | 44.67M USD |
Diluted EPS (ttm) | 3.07 |
Quarterly Earnings Growth (yoy) | -15.59% |
Balance Sheet
Total Cash (mrq) | 250.94M USD |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 22.17M USD |
Total Debt/Equity (mrq) | 3.98 USD |
Current Ratio (mrq) | 3.119 |
Book Value Per Share (mrq) | 30.673 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Boiron SA
Country | United States |
State | N/A |
City | Messimy |
Address | 2, avenue de l’Ouest Lyonnais |
ZIP | 69510 |
Phone | 33 4 78 45 61 00 |
Website | https://www.boiron.fr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2801 |
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Q&A For Boiron SA Stock
What is a current BOIRF stock price?
Boiron SA BOIRF stock price today per share is 28.5 USD.
How to purchase Boiron SA stock?
You can buy BOIRF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Boiron SA?
The stock symbol or ticker of Boiron SA is BOIRF.
Which industry does the Boiron SA company belong to?
The Boiron SA industry is Drug Manufacturers-Specialty & Generic.
How many shares does Boiron SA have in circulation?
The max supply of Boiron SA shares is 17.36M.
What is Boiron SA Price to Earnings Ratio (PE Ratio)?
Boiron SA PE Ratio is 20.07042300 now.
What was Boiron SA earnings per share over the trailing 12 months (TTM)?
Boiron SA EPS is 1.42 USD over the trailing 12 months.
Which sector does the Boiron SA company belong to?
The Boiron SA sector is Healthcare.